News
Potential new diagnostic tools
March 23, 2023
The Tj Whalen Foundation announces a collaboration with RSDSA (Reflexive Sympathetic Dystrophy Syndr...
News
New Orphan Drug Approved for Clinical Trials
October 13, 2021
FDA grants orphan drug status for use of Ketamine in clinical trials for CRPS...
News
New Orphan Drug Approved for Clinical Trials
September 9, 2021
FDA grants orphan drug status for Low Dose Naltrexone (LDN) in trials for CRPS...
News
The Passing of a Pioneer
August 25, 2021
Dr. Robert Shwartzman, the gold standard in compassionate CRPS treatment and research, passed away a...
News
Stanford University Begins Clinical Trials of LDN
August 25, 2020
Stanford pain clinic announces initiation of clinical trials using Low Dose Naltrexone (LDN) and is ...
News
Sample Post
August 25, 2020
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore...